Sponsor:
Mount Sinai Hospital, Canada
Code:
NCT03646006
Conditions
Pain, Postoperative
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine
Placebo
Brief summary:
Conditions
Pain, Postoperative
Study ID
NCT03646006
Start date
Aug 1, 2018
Status verified date
Aug, 2018
Completion date
Jul, 2019
Anticipated
Primary completion date
Mar, 2019
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Pre-sacral nerve block
sham comparator: Sham block
Interventions
Bupivacaine
Placebo
Primary outcome measure
Central contacts
Locations
Mount Sinai Hospital
Recruiting
Toronto, Ontario, Canada, M5G1Z5
Contacts
Sponsor
Mount Sinai Hospital, Canada
Last update posted
Aug 27, 2018
Last verified
Aug, 2018
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mount Sinai Hospital, Canada on 2018-08-27.